A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Clinical trial NCT06431373 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06431373
Sponsor: Priovant Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Uveitis, Posterior Uveitis, Intermediate Uveitis

Start date: 2024-09-11
Primary completion: 2026-09-11
Enrollment: 371

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.